Jack F. Bukowski

5.9k total citations
70 papers, 4.8k citations indexed

About

Jack F. Bukowski is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Jack F. Bukowski has authored 70 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 25 papers in Rheumatology and 12 papers in Epidemiology. Recurrent topics in Jack F. Bukowski's work include Immune Cell Function and Interaction (30 papers), T-cell and B-cell Immunology (19 papers) and Rheumatoid Arthritis Research and Therapies (19 papers). Jack F. Bukowski is often cited by papers focused on Immune Cell Function and Interaction (30 papers), T-cell and B-cell Immunology (19 papers) and Rheumatoid Arthritis Research and Therapies (19 papers). Jack F. Bukowski collaborates with scholars based in United States, France and Netherlands. Jack F. Bukowski's co-authors include Craig T. Morita, Raymond M. Welsh, Michael B. Brenner, Hiranmoy Das, Bruce A. Woda, Arati B. Kamath, Lisheng Wang, Yoshimasa Tanaka, Hamid Band and John F. Warner and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jack F. Bukowski

68 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack F. Bukowski United States 34 3.4k 872 831 712 367 70 4.8k
Catherine S. Tripp United States 24 3.3k 1.0× 720 0.8× 315 0.4× 701 1.0× 1.0k 2.7× 30 5.3k
Shahla Abdollahi‐Roodsaz Netherlands 30 1.9k 0.5× 385 0.4× 902 1.1× 325 0.5× 1.4k 3.8× 50 3.6k
Birgit Strobl Austria 38 2.0k 0.6× 546 0.6× 189 0.2× 1.4k 2.0× 1.8k 4.9× 97 4.6k
Giorgos Bamias Greece 44 2.2k 0.7× 1.2k 1.4× 288 0.3× 574 0.8× 1.4k 3.9× 131 5.4k
Barbara Bohle Austria 49 1.4k 0.4× 230 0.3× 311 0.4× 169 0.2× 946 2.6× 183 8.0k
Hans‐Dieter Flad Germany 40 2.2k 0.7× 489 0.6× 105 0.1× 900 1.3× 934 2.5× 90 4.2k
J. Berth‐Jones United Kingdom 41 1.6k 0.5× 994 1.1× 580 0.7× 210 0.3× 404 1.1× 136 5.7k
Donald D. Anthony United States 36 1.3k 0.4× 756 0.9× 337 0.4× 433 0.6× 1.1k 3.0× 128 3.9k
Franco Pandolfi Italy 33 1.9k 0.6× 448 0.5× 215 0.3× 580 0.8× 829 2.3× 155 3.5k
Alan D. Levine United States 38 2.0k 0.6× 591 0.7× 175 0.2× 550 0.8× 1.2k 3.2× 113 4.3k

Countries citing papers authored by Jack F. Bukowski

Since Specialization
Citations

This map shows the geographic impact of Jack F. Bukowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack F. Bukowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack F. Bukowski more than expected).

Fields of papers citing papers by Jack F. Bukowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack F. Bukowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack F. Bukowski. The network helps show where Jack F. Bukowski may publish in the future.

Co-authorship network of co-authors of Jack F. Bukowski

This figure shows the co-authorship network connecting the top 25 collaborators of Jack F. Bukowski. A scholar is included among the top collaborators of Jack F. Bukowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack F. Bukowski. Jack F. Bukowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maksymowych, Walter P., Pascal Claudepierre, Manouk de Hooge, et al.. (2024). Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort). The Journal of Rheumatology. 51(5). 462–471.
2.
Przybylski, Grzegorz, et al.. (2023). TB and COVID-19 co-infection in a pulmonology hospital. The International Journal of Tuberculosis and Lung Disease. 27(7). 574–576.
3.
4.
Maksymowych, Walter P., Stephanie Wichuk, Maxime Dougados, et al.. (2017). MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation. Arthritis Research & Therapy. 19(1). 126–126. 40 indexed citations
5.
Maksymowych, Walter P., Stephanie Wichuk, Maxime Dougados, et al.. (2017). Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis. Annals of the Rheumatic Diseases. 77(1). 78–84. 36 indexed citations
6.
Wiland, Piotr, Jean Dudler, Douglas J. Veale, et al.. (2016). The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis. The Journal of Rheumatology. 43(7). 1268–1277. 10 indexed citations
7.
Maksymowych, Walter P., Maxime Dougados, Désirée van der Heijde, et al.. (2015). Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study. Annals of the Rheumatic Diseases. 75(7). 1328–1335. 80 indexed citations
8.
Emery, Paul, Oliver FitzGerald, Bernard Combe, et al.. (2014). Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis. New England Journal of Medicine. 371(19). 1781–1792. 134 indexed citations
9.
Attur, Mukundan, Jack F. Bukowski, N. Aziz, et al.. (2009). Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations. Annals of the Rheumatic Diseases. 69(5). 856–861. 53 indexed citations
10.
Percival, Susan S., Jack F. Bukowski, & John Milner. (2008). Bioactive Food Components that Enhance γδ T Cell Function May Play a Role in Cancer Prevention. Journal of Nutrition. 138(1). 1–4. 33 indexed citations
11.
Nantz, Meri P., Cheryl A. Rowe, Jack F. Bukowski, & Susan S. Percival. (2008). Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition. 25(2). 147–154. 85 indexed citations
12.
Rowe, Cheryl A., Meri P. Nantz, Jack F. Bukowski, & Susan S. Percival. (2007). Specific Formulation ofCamellia sinensisPrevents Cold and Flu Symptoms and Enhances γδ T Cell Function: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of the American College of Nutrition. 26(5). 445–452. 57 indexed citations
13.
Xiong, Xiaowei, Craig T. Morita, Jack F. Bukowski, Michael B. Brenner, & Christopher C. Dascher. (2004). Identification of guinea pig γδ T cells and characterization during pulmonary tuberculosis. Veterinary Immunology and Immunopathology. 102(1-2). 33–44. 4 indexed citations
14.
Wang, Hong, Hoi K. Lee, Jack F. Bukowski, et al.. (2003). Conservation of Nonpeptide Antigen Recognition by Rhesus Monkey Vγ2Vδ2 T Cells. The Journal of Immunology. 170(7). 3696–3706. 50 indexed citations
15.
Wang, Lisheng, Hiranmoy Das, Arati B. Kamath, Li Lin, & Jack F. Bukowski. (2002). Human Vγ2Vδ2 T Cells Augment Migration-Inhibitory Factor Secretion and Counteract the Inhibitory Effect of Glucocorticoids on IL-1β and TNF-α Production. The Journal of Immunology. 168(10). 4889–4896. 9 indexed citations
16.
Wang, Lisheng, Hiranmoy Das, Arati B. Kamath, & Jack F. Bukowski. (2001). Human Vγ2Vδ2 T Cells Produce IFN-γ and TNF-α with an On/Off/On Cycling Pattern in Response to Live Bacterial Products. The Journal of Immunology. 167(11). 6195–6201. 70 indexed citations
17.
Bukowski, Jack F., Maria Grazia Roncarolo, Hergen Spits, et al.. (2000). T cell receptor-dependent activation of human lymphocytes through cell surface ganglioside GT1b: implications for innate immunity. European Journal of Immunology. 30(11). 3199–3206. 5 indexed citations
18.
Morita, Craig T., Evan Beckman, Jack F. Bukowski, et al.. (1995). Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity. 3(4). 495–507. 406 indexed citations
19.
Bukowski, Jack F. & Raymond M. Welsh. (1985). Interferon enhances the susceptibility of virus-infected fibroblasts to cytotoxic T cells.. The Journal of Experimental Medicine. 161(1). 257–262. 89 indexed citations
20.
Bukowski, Jack F., John F. Warner, Gunther Dennert, & Raymond M. Welsh. (1985). Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.. The Journal of Experimental Medicine. 161(1). 40–52. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026